Page last updated: 2024-08-23
simvastatin and mk0767
simvastatin has been researched along with mk0767 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Berger, JP; Biswas, C; Chao, YS; Doebber, TW; Ippolito, MC; Kelly, LJ; Li, Y; Meurer, R; Moller, DE; Wang, PR; Wright, SD; Wu, MS; Zhou, G | 1 |
Other Studies
1 other study(ies) available for simvastatin and mk0767
| Article | Year |
|---|---|
MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities.
Topics: Animals; Benzamides; Blood Glucose; Chlorocebus aethiops; Cholesterol; COS Cells; Cricetinae; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Mesocricetus; Mice; Mice, Obese; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Simvastatin; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcriptional Activation; Triglycerides | 2004 |